BDBM72374 1-(2-pyridinylmethyl)-3-[3-(trifluoromethyl)phenyl]thiourea::1-(2-pyridylmethyl)-3-[3-(trifluoromethyl)phenyl]thiourea::1-(pyridin-2-ylmethyl)-3-[3-(trifluoromethyl)phenyl]thiourea::MLS000681226::N-(2-pyridinylmethyl)-N'-[3-(trifluoromethyl)phenyl]thiourea::SMR000269490::cid_883359

SMILES FC(F)(F)c1cccc(NC(=S)NCc2ccccn2)c1

InChI Key InChIKey=GGQZXCOCGXDMHR-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72374   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72374BDBM72374(2,3,9-Trifluoro-8-(trifluoromethoxy)-10,11,12,13-t...)
Affinity DataIC50: 12.6nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details US Patent